Kumiko Okada

Title: Kumiko Okada: Innovator in Pharmaceutical Chemistry

Introduction

Kumiko Okada is a prominent inventor based in Toshima-ku, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for therapeutic applications. Her work focuses on addressing various mental health disorders and cognitive dysfunctions.

Latest Patents

Kumiko Okada holds 1 patent for her invention of an Ethinyl-pyrazole derivative. This novel compound is represented by a specific formula and is recognized for its antagonistic activity against group II metabolism-type glutamic acid (m-Glu) receptors. The compound or its pharmaceutically acceptable salt is intended for use as a prophylactic or therapeutic agent for a range of diseases, including mood disorders, anxiety disorders, schizophrenia, Alzheimer's disease, and various sleep disorders.

Career Highlights

Kumiko Okada is associated with Taisho Pharmaceutical Co., Ltd., where she has been instrumental in advancing research and development in the pharmaceutical sector. Her innovative approach and dedication to improving mental health treatments have positioned her as a key figure in her field.

Collaborations

Kumiko has collaborated with notable colleagues, including Toshio Nakamura and Kazunari Sakagami, to further enhance the impact of her research and inventions.

Conclusion

Kumiko Okada's contributions to pharmaceutical chemistry exemplify her commitment to innovation and improving healthcare outcomes. Her work continues to inspire advancements in the treatment of complex mental health conditions.